About VERO Biotech: VERO Biotech’s mission is to improve the lives of patients by developing innovative technologies for inhaled nitric oxide delivery in the acute care hospital setting and beyond; wherever nitric oxide treatment is needed. VERO Biotech strives to exceed customer expectations in safety, efficacy, and value by focusing on the science, development, and commercialization of our innovations. VERO Biotech Enlists Advarra Consulting to Provide Guidance for FDA Approval Executive Summary After working for nearly 10 years to develop a nitric oxide and a delivery device for babies treated at hospitals in newborn intensive care units (NICU), VERO Biotech, a growing biotech company was anxious to move forward and bring its exciting, breakthrough combination drug and device to

Join for free to read